Valiant Organics to buy 34.26% stake in Valiant Labs

Valiant Organics Limited has proposed the acquisition of 1,86,07,531 equity shares, representing a 34.26% stake, in Valiant Laboratories Limited . The shares will be purchased from Dhanvallabh Ventures LLP through an off-market transaction. This acquisition is part of a broader restructuring exercise being undertaken by Valiant Organics Limited and is subject to the receipt of requisite approvals.

The transaction is scheduled to take place any time after four working days from the date of intimation, which was May 19, 2026. The acquisition price will not exceed the limits provided in the proviso to Regulation 10(1)(a) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The volume weighted average market price for the 60 trading days preceding the notice was Rs. 62.71 per equity share.

Transaction Details and Rationale

The acquirer, Valiant Organics Limited, is a member of the promoter group of the target company. The proposed acquisition is exempt from making an open offer under Regulation 10(1)(a)(iii) of the Takeover Regulations. The rationale provided for this move is the ongoing restructuring exercise aimed at achieving strategic synergies.

Parameter Details Target Company Valiant Laboratories Limited Acquirer Valiant Organics Limited Seller Dhanvallabh Ventures LLP Shares to be Acquired 1,86,07,531 Stake Acquired 34.26% VWAP (60 days) Rs. 62.71 per share

Shareholding Pattern

Following the transaction, the shareholding structure of Valiant Laboratories Limited will undergo significant changes. Dhanvallabh Ventures LLP will see its holding reduce from 46.84% to 12.58%, while Valiant Organics Limited will emerge with a 34.26% stake.

Shareholder Pre-Transaction Shares Pre-Transaction % Post-Transaction Shares Post-Transaction % Valiant Organics Limited - - 1,86,07,531 34.26 Dhanvallabh Ventures LLP 2,54,37,500 46.84 68,29,969 12.58

The Board of Directors of Valiant Laboratories Limited had previously accorded in-principle approval on May 16, 2026, to explore potential restructuring options. This evaluation was aimed at achieving operational, organizational, and strategic synergies. The current acquisition by the promoter group entity aligns with the board's objective of unlocking long-term value and enhancing the clarity of the business profile.

Valiant Laboratories Limited has published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, in newspapers Financial Express (English) and Mumbai Lakshadeep (Marathi) on May 16, 2026, in compliance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were previously reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on May 14, 2026, in Mumbai. The intimation has also been uploaded on the company's website at www.valiantlabs.in .

Standalone Financial Performance

On a standalone basis, the company delivered a strong turnaround in FY26, swinging to a net profit of ₹554.82 lakhs compared to a net loss of ₹215.02 lakhs in the previous year. Revenue from operations rose significantly to ₹21,704.25 lakhs from ₹13,336.18 lakhs in FY25. For the quarter ended March 31, 2026, the standalone net profit stood at ₹353.28 lakhs on total income of ₹6,607.61 lakhs. The standalone results reflect a pre-tax profit of ₹754.79 lakhs for FY26, compared to a pre-tax loss of ₹144.78 lakhs in FY25.

Metric Q4 FY26 (₹ Lakhs) FY26 (₹ Lakhs) Q4 FY25 (₹ Lakhs) FY25 (₹ Lakhs) Revenue from Operations 6,530.34 21,704.25 5,777.00 13,336.18 Total Income 6,607.61 21,993.73 5,842.39 13,878.99 Net Profit/(Loss) before Tax 473.49 754.79 392.36 (144.78) Net Profit/(Loss) after Tax 353.28 554.82 323.83 (215.02) Total Comprehensive Income 352.03 554.39 321.56 (217.28) Basic EPS (₹) 0.65 1.02 0.74 (0.50) Diluted EPS (₹) 0.70 1.10 0.74 (0.50)

Consolidated Financial Performance

On a consolidated basis, which includes subsidiary Valiant Advanced Sciences Private Limited, the group reported a net loss of ₹326.79 lakhs for FY26. Revenue from operations for the year increased to ₹23,746.75 lakhs. The consolidated results reflect higher costs associated with the subsidiary's operations, resulting in a net loss for the full year despite a profit of ₹175.87 lakhs in Q4 FY26. The consolidated pre-tax profit for the quarter stood at ₹104.68 lakhs.

Metric Q4 FY26 (₹ Lakhs) FY26 (₹ Lakhs) Q4 FY25 (₹ Lakhs) FY25 (₹ Lakhs) Revenue from Operations 9,198.18 23,746.75 5,778.56 13,338.20 Total Income 9,215.30 23,978.79 5,547.10 13,881.68 Net Profit/(Loss) before Tax 104.68 76.82 93.91 (151.26) Net Profit/(Loss) after Tax 175.87 (326.79) 70.36 (220.12) Total Comprehensive Income 176.07 (326.37) 67.96 (222.52) Basic EPS (₹) 0.32 (0.51) 0.16 (0.51) Diluted EPS (₹) 0.35 (0.51) 0.16 (0.51)

Additional Financial Details

The paid-up equity share capital stood at ₹5,431.25 lakhs as of March 31, 2026, compared to ₹4,345.00 lakhs in the previous year, on both standalone and consolidated basis. Reserves excluding revaluation reserves as per the balance sheet stood at ₹26,544.62 lakhs (standalone) and ₹25,657.26 lakhs (consolidated) for FY26, against ₹19,093.31 lakhs and ₹19,086.01 lakhs respectively in FY25. The financial results have been prepared in accordance with Indian Accounting Standards (IndAS) as prescribed under Section 133 of the Companies Act, 2013, and are available on the BSE, NSE, and the company's website. The full format of the financial results is accessible at www.bseindia.com , www.nseindia.com , and www.valiantlabs.in .

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.